Thinking like pediatricians to prevent pneumococcal disease in adults
- 3 April 2025
- journal article
- Published by Elsevier in Enfermedades Infecciosas y Microbiologia Clinica (English Ed.)
- Vol. 43 (4) , 185-187
Abstract
No abstract availableThis publication has 19 references indexed in Scilit:
- Invasive pneumococcal disease in a tertiary hospital in Madrid: are we using pneumococcal vaccine correctly?Enfermedades Infecciosas y Microbiología Clínica, 2024
- Effectiveness of pneumococcal vaccination in adults with common immune-mediated inflammatory diseases in the UK: a case–control studyThe Lancet Rheumatology, 2024
- Surveillance of invasive pneumococcal disease in Spain exploring the impact of the COVID-19 pandemic (2019-2023)Journal of Infection, 2024
- Association of Pneumococcal Conjugate Vaccine Use With Hospitalized Pneumonia in Medicare Beneficiaries 65 Years or Older With and Without Medical Conditions, 2014 to 2017JAMA Internal Medicine, 2023
- Immunogenicity and safety of the 13-valent pneumococcal conjugate vaccine in patients with immunocompromising conditions: a review of available evidenceHuman Vaccines & Immunotherapeutics, 2020
- Factors influencing long-term survival after hospitalization with pneumococcal pneumoniaJournal of Infection, 2019
- Impact of existing vaccines in reducing antibiotic resistance: Primary and secondary effectsProceedings of the National Academy of Sciences, 2018
- Incidence of invasive pneumococcal disease in immunocompromised patients: A systematic review and meta-analysisTravel Medicine and Infectious Disease, 2018
- Long-term mortality after IPD and bacteremic versus non-bacteremic pneumococcal pneumoniaVaccine, 2017
- Polysaccharide Conjugate Vaccine against Pneumococcal Pneumonia in AdultsNew England Journal of Medicine, 2015